CliniMacs®

DEVICE2 trials

Sponsors

Christopher Dvorak, Nationwide Children's Hospital

Conditions

Graft Vs Host DiseaseGraft-versus-host-diseaseHematologic MalignancyHematopoietic Stem Cell Transplantation

Unknown Phase

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

RecruitingNCT04337515

Christopher DvorakGraft-versus-host-disease, Graft Vs Host Disease

Start: 2019-12-19End: 2035-01-01Target: 90Updated: 2026-04-13

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

RecruitingNCT06082947

Nationwide Children's HospitalHematologic Malignancy, Hematopoietic Stem Cell Transplantation

Start: 2023-12-18End: 2030-12-01Target: 50Updated: 2025-04-02

Related Papers

Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy

Blood Advances2024-07-239 citations